Oramed Pharmaceuticals
ORMP
#8899
Rank
A$0.19 B
Marketcap
A$4.80
Share price
1.20%
Change (1 day)
49.20%
Change (1 year)

Market capitalization of Oramed Pharmaceuticals (ORMP)

Market cap: A$0.19 Billion

As of March 2026 Oramed Pharmaceuticals has a market cap of A$0.19 Billion. This makes Oramed Pharmaceuticals the world's 8899th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Oramed Pharmaceuticals from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.19 B9%
2025A$0.17 B14.26%
2024A$0.15 B12.3%
2023A$0.13 B-80.22%
2022A$0.69 B-8%
2021A$0.75 B472.46%
2020A$0.13 B2.58%
2019A$0.12 B72.95%
2018A$74 M-55.13%
2017A$0.16 B46.42%
2016A$0.11 B-17.28%
2015A$0.13 B126.03%
2014A$60.24 M-56.18%
2013A$0.13 B400.5%
2012A$27.46 M43.49%
2011A$19.14 M10.32%
2010A$17.35 M-39.25%
2009A$28.56 M-8.46%
2008A$31.2 M

End of Day market cap according to different sources

On Mar 3rd, 2026 the market cap of Oramed Pharmaceuticals was reported to be:

A$0.19 Billion
by Nasdaq info icon info icon
A$0.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novo Nordisk
NVO
A$231.43 B 120,883.13%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
A$159.39 B 83,225.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
A$3.02 B 1,483.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A$0.95 B 399.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A$0.26 B 39.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel